HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Erratum An erratum has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by KHALIL, I. Articles by BYGBJERG, I. C. Search for Related Content PubMed PubMed Citation Articles by KHALIL, I. Articles by BYGBJERG, I. C. Related Collections Malaria

DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE GENOTYPES ASSOCIATED WITH IN VITRO RESISTANCE OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE, TRIMETHOPRIM, SULFADOXINE, AND SULFAMETHOXAZOLE

A total of 70 Plasmodium falciparum isolates were tested in vitro against pyrimethamine (PYR), tri-methoprim (TRM), sulfadoxine (SDX), and sulfamethoxazole (SMX), and their dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genotypes were determined. dhfr genotypes correlated with PYR and TRM drug responses (r = 0.93 and 0.85). Isolates with wild-type alleles showed mean half inhibitory concentrations (IC₅₀ ± SD) of 0.10 ± 0.10 and 0.15 ± 0.06 µg/100 µl for PYR and TRM. Parasites with mutations at codons 108 and 51 alone or combined with codon 59 have IC₅₀ of 11.46 ± 0.86 (PYR) and 2.90 ± 0.59 µg/100 µl (TRM). For both drugs, the differences in the mean IC₅₀ between wild and mutant parasites were statistically significant (P < 0.001). Isolates with mixed wild and mutant alleles showed an intermediate level of susceptibility. Our data show partial cross-resistance between PYR/TRM and SDX/SMX (r = 0.85 and 0.65). Correlation was not observed between different dhps genotypes and the in vitro outcome to SDX and SMX (r = 0.30 and 0.34). The lack of correlation could be due to folates and para-aminobenzoic acid in the RPMI medium and the serum used to supplement the cultures.

Acknowledgments: We thank Mr. Jimmy Weng, for technical assistance; Dr. Thor Theander and Dr. Donath Tarimo, for critical comments and help; and the Malaria Research Group in the Biochemistry Department, Faculty of Medicine, University of Khartoum.

Financial support: This work was supported by the Danish International Development Agency (DANIDA).

Authors’ Addresses: Insaf Khalil and Michael Alifrangis, Center for Medical Parasitology, Institute of Medical Microbiology and Immunology, University of Copenhagen, Panum Institute, Building 24.2, Blegdamsvej 3, 2200 Copenhagen N, Denmark and Department of Infectious Diseases, Copenhagen University Hospital, Tagensvej 20, 2200 Copenhagen N, Denmark. Anita M. Rønn, Department of Clinical Pharmacology, Copenhagen University Hospital, Tagensvej 20, 2200, Copenhagen N, Denmark. Haytham A. Gabar, Department of Biochemistry, Faculty of Medicine, University of Khartoum, Sudan, P.O. Box 102. Gwiria M. H. Satti, Department of Biochemistry, P.O. Box 2114, King Faisal University, Dammam, Saudi Arabia. Ib C. Bygbjerg, Institute of Public Health, University of Copenhagen, Panum Institute, Building 42, Blegdamsvej 3, 2200 Copenhagen N, Denmark.

Reprint requests: Insaf Khalil, Center for Medical Parasitology, Institute of Medical Microbiology and Immunology, University of Copenhagen, Panum Institute, Building 24,2, Blegdamsvej 3, 2200, Copenhagen N, Denmark, Telephone: + 45 35 32 76 80, Fax: + 45 35 32 78 51, E-mail: InsafK{at}hotmail.com

This article has been cited by other articles:

				S. M. Kiara, J. Okombo, V. Masseno, L. Mwai, I. Ochola, S. Borrmann, and A. Nzila In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3793 - 3798. [Abstract] [Full Text] [PDF]

				C. Barnadas, L. Musset, E. Legrand, M. Tichit, S. Briolant, T. Fusai, C. Rogier, C. Bouchier, S. Picot, and D. Menard High Prevalence and Fixation of Plasmodium vivax dhfr/dhps Mutations Related to Sulfadoxine/Pyrimethamine Resistance in French Guiana Am J Trop Med Hyg, July 1, 2009; 81(1): 19 - 22. [Abstract] [Full Text] [PDF]

				A. M. McCollum, K. Mueller, L. Villegas, V. Udhayakumar, and A. A. Escalante Common Origin and Fixation of Plasmodium falciparum dhfr and dhps Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in a Low-Transmission Area in South America Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2085 - 2091. [Abstract] [Full Text] [PDF]

				M. C. Costa, F. Esteves, F. Antunes, and O. Matos Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal J. Antimicrob. Chemother., December 1, 2006; 58(6): 1246 - 1249. [Abstract] [Full Text] [PDF]

				D. MENARD, F. YAPOU, A. MANIRAKIZA, D. DJALLE, M. D. MATSIKA-CLAQUIN, and A. TALARMIN Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from bangui, central african republic. Am J Trop Med Hyg, September 1, 2006; 75(3): 381 - 387. [Abstract] [Full Text] [PDF]

				F. Marks, J. Evans, C. G. Meyer, E. N. Browne, C. Flessner, V. von Kalckreuth, T. A. Eggelte, R. D. Horstmann, and J. May High Prevalence of Markers for Sulfadoxine and Pyrimethamine Resistance in Plasmodium falciparum in the Absence of Drug Pressure in the Ashanti Region of Ghana Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1101 - 1105. [Abstract] [Full Text] [PDF]

				A. Gregson and C. V. Plowe Mechanisms of Resistance of Malaria Parasites to Antifolates Pharmacol. Rev., March 1, 2005; 57(1): 117 - 145. [Abstract] [Full Text] [PDF]

				G. DORSEY, C. DOKOMAJILAR, M. KIGGUNDU, S. G. STAEDKE, M. R. KAMYA, and P. J. ROSENTHAL PRINCIPAL ROLE OF DIHYDROPTEROATE SYNTHASE MUTATIONS IN MEDIATING RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SINGLE-DRUG AND COMBINATION THERAPY OF UNCOMPLICATED MALARIA IN UGANDA Am J Trop Med Hyg, December 1, 2004; 71(6): 758 - 763. [Abstract] [Full Text] [PDF]

				C. J. VREUGDENHIL, F. Y. SCHEPER, S. R. HOOGSTRAATTE, M. SMOLDERS, S. GIKUNDA, F. G. COBELENS, and P. A. KAGER COMPARISON OF THE PARASITOLOGIC EFFICACY OF AMODIAQUINE AND SULFADOXINE-PYRIMETHAMINE IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA IN THE BUNGOMA DISTRICT OF WESTERN KENYA Am J Trop Med Hyg, November 1, 2004; 71(5): 537 - 541. [Abstract] [Full Text] [PDF]

				A. Mbaisi, P. Liyala, F. Eyase, R. Achilla, H. Akala, J. Wangui, J. Mwangi, F. Osuna, U. Alam, B. L. Smoak, et al. Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of Kenya Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3598 - 3601. [Abstract] [Full Text] [PDF]